The newly submitted NDA from Abbvie has released another study result, this time, on Japanese HCV genotype-1 patients. "Overall, 105 of 106 patients (99%) without cirrhosis and without the Y93H variant achieved SVR12."
Investigational HCV regimen highly ef... - HFI Connect - Hep...
Investigational HCV regimen highly effective in Japanese genotype-1 patients
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
